Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP905678.RAoHZ9VKSUGAyeOow9CJdGy61If73fLakt1NFXJ35kQog130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905678.RAoHZ9VKSUGAyeOow9CJdGy61If73fLakt1NFXJ35kQog130_provenance.
• NP940016.RAmFkBy9-ulIeP9yKGClKIo5eHj3FRBljqbyjaaBMpfM4130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP940016.RAmFkBy9-ulIeP9yKGClKIo5eHj3FRBljqbyjaaBMpfM4130_provenance.
• NP292118.RAcUkfR-gv5AOIA0TWI_do4366v6-3ZSx5r1e-r7M-Psk130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP292118.RAcUkfR-gv5AOIA0TWI_do4366v6-3ZSx5r1e-r7M-Psk130_provenance.
• NP378686.RAjdzA-NzqTpJmGsTJkzAuBpL02Z7K8K32qbMytI78lSY130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP378686.RAjdzA-NzqTpJmGsTJkzAuBpL02Z7K8K32qbMytI78lSY130_provenance.
• NP903853.RAXvYMJHbYEESeSV1SxnaJ-tFibq8nAwL5b5SHTkWvA8I130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP903853.RAXvYMJHbYEESeSV1SxnaJ-tFibq8nAwL5b5SHTkWvA8I130_provenance.
• NP524756.RA6V2g1VT1FgOlfNuBqATAaz9t_106P0teN1XJi2eyPbk130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524756.RA6V2g1VT1FgOlfNuBqATAaz9t_106P0teN1XJi2eyPbk130_provenance.
• NP812878.RAo6jLjl6tS0oriOeUwNstIPWXV3WbMFfm8lvD5E8UijU130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP812878.RAo6jLjl6tS0oriOeUwNstIPWXV3WbMFfm8lvD5E8UijU130_provenance.
• assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP614010.RAzJRCwiZvXM8FB9050hPAeQXuZOWtqBlQsjIHTUoBVgc130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP614010.RAzJRCwiZvXM8FB9050hPAeQXuZOWtqBlQsjIHTUoBVgc130_provenance.
• assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP111961.RATklhoXk-pumpQj4blYIZjMMuJo4mE3pb0jLJBg_0AmQ130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111961.RATklhoXk-pumpQj4blYIZjMMuJo4mE3pb0jLJBg_0AmQ130_provenance.
• NP517972.RAURMsAEflghZWyaavBhgHbOvfvQKAfzhogXizDv39DEM130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP517972.RAURMsAEflghZWyaavBhgHbOvfvQKAfzhogXizDv39DEM130_provenance.
• NP895215.RA9OQo_Ojgim3yJCTrBY40pP32OmYAi8pTINw3axh7wCU130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP895215.RA9OQo_Ojgim3yJCTrBY40pP32OmYAi8pTINw3axh7wCU130_provenance.
• assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP106920.RArxDjmYTPQXlVuBVwvt_ExHpNCZ2woqvfLYHoGi2ZYCc130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP106920.RArxDjmYTPQXlVuBVwvt_ExHpNCZ2woqvfLYHoGi2ZYCc130_provenance.
• NP111437.RAu_WsYIF8FZEeyvn2Yw6kzgRItEc-pSc6mRmH--CYZ7E130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111437.RAu_WsYIF8FZEeyvn2Yw6kzgRItEc-pSc6mRmH--CYZ7E130_provenance.
• NP137269.RAUYq1PElxkNoR_-2lx8-pxQUbieSyhOqzfZ5IY-5uLpY130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP137269.RAUYq1PElxkNoR_-2lx8-pxQUbieSyhOqzfZ5IY-5uLpY130_provenance.
• NP137274.RAZetZbeFERVK0_o0fTWPolvP3IBS4GicGAC2DPxhyNDc130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP137274.RAZetZbeFERVK0_o0fTWPolvP3IBS4GicGAC2DPxhyNDc130_provenance.
• NP70321.RAlE1cw65VPeYRNaMCp3LAu-OOJEjxiwbqLuw1AkANO8U130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP70321.RAlE1cw65VPeYRNaMCp3LAu-OOJEjxiwbqLuw1AkANO8U130_provenance.
• NP115773.RAqwNA889HxgKUr-Wy54JNeq1ou3SQsNsaKCbKHi4ZKQs130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP115773.RAqwNA889HxgKUr-Wy54JNeq1ou3SQsNsaKCbKHi4ZKQs130_provenance.
• NP341585.RABvVevdFOibWyC28gh5oWiEz5juinut24_bejHHpTwS8130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP341585.RABvVevdFOibWyC28gh5oWiEz5juinut24_bejHHpTwS8130_provenance.
• NP115769.RABmUqS0FSLzQpYtMrH5XZOzTrq-nWCae0TWVR_FhfI2I130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP115769.RABmUqS0FSLzQpYtMrH5XZOzTrq-nWCae0TWVR_FhfI2I130_provenance.
• NP137271.RACtTmmJVs_9sBbfb5G3AuRSG5ZIo0WU7MNclFJUURWNw130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP137271.RACtTmmJVs_9sBbfb5G3AuRSG5ZIo0WU7MNclFJUURWNw130_provenance.
• NP517955.RAof7b5cmQSTiEpXmATh7iGk_-tKy5aKk_hg3V7kOeK-A130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP517955.RAof7b5cmQSTiEpXmATh7iGk_-tKy5aKk_hg3V7kOeK-A130_provenance.
• NP940041.RAr5NA8Oa-yYSW0CZptN-omSU0uWfooJ79KaEc4XJX6_k130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP940041.RAr5NA8Oa-yYSW0CZptN-omSU0uWfooJ79KaEc4XJX6_k130_provenance.
• NP940044.RAkvNHBr2gLDUoUWSCJE6kJLutnTdbLYNhdO-5t7ePZBE130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP940044.RAkvNHBr2gLDUoUWSCJE6kJLutnTdbLYNhdO-5t7ePZBE130_provenance.
• NP710951.RATUtSE6rj2ozVAYd4u1c3KpCZs-4kiLuE437J0ncg4sQ130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710951.RATUtSE6rj2ozVAYd4u1c3KpCZs-4kiLuE437J0ncg4sQ130_provenance.
• NP618390.RABbGnoD6_AUMM3YhWgSWsL5xBmEA0BlUkBBNOlMX8wso130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618390.RABbGnoD6_AUMM3YhWgSWsL5xBmEA0BlUkBBNOlMX8wso130_provenance.
• NP710958.RABSrCdZo9Qcxy-CnpY_iVludYv_UGFmyl4iEhT5xhNpU130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710958.RABSrCdZo9Qcxy-CnpY_iVludYv_UGFmyl4iEhT5xhNpU130_provenance.
• assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP341618.RAkEX4QbJMd1N2f-WvcBBhDrtp8sWGN6UdUV7oNVo569s130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP341618.RAkEX4QbJMd1N2f-WvcBBhDrtp8sWGN6UdUV7oNVo569s130_provenance.
• NP137270.RAmIyFQgHDEHCStJy_q0MknIoBFwwuQkmKO2HiTzLHlJw130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP137270.RAmIyFQgHDEHCStJy_q0MknIoBFwwuQkmKO2HiTzLHlJw130_provenance.
• NP710955.RAme7e5BYvw1fmmk4SV-UA9X5RxhtRhmiNvqlN800zQuo130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710955.RAme7e5BYvw1fmmk4SV-UA9X5RxhtRhmiNvqlN800zQuo130_provenance.
• NP618254.RAhCZMu0_6p4Y1cdeL1I1LcKBv3mkvgzX4TDk6ERSizts130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618254.RAhCZMu0_6p4Y1cdeL1I1LcKBv3mkvgzX4TDk6ERSizts130_provenance.
• NP844554.RAK-fSNBlbEeMOdgTf8cs5vMGOKQ2ZrDxE7cPQOlhndkg130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP844554.RAK-fSNBlbEeMOdgTf8cs5vMGOKQ2ZrDxE7cPQOlhndkg130_provenance.
• NP70383.RALbDtWGXC56Wklz6WKKYK6dKoUESpZ06inxi7qCBhoTM130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP70383.RALbDtWGXC56Wklz6WKKYK6dKoUESpZ06inxi7qCBhoTM130_provenance.
• NP111434.RAyj-sBhEsKbbwyiRvAeXP-eE9vDWDPdlzBjo_20F3kcs130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111434.RAyj-sBhEsKbbwyiRvAeXP-eE9vDWDPdlzBjo_20F3kcs130_provenance.
• NP106926.RAOCZ_HOxC1y62NFpgP-yYId2hF2SofvOYsv6eWpzAdhE130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP106926.RAOCZ_HOxC1y62NFpgP-yYId2hF2SofvOYsv6eWpzAdhE130_provenance.
• NP111894.RAF3ERlCqATNhIs1ibSoE-GqITCKdcja1srqttUge06A8130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111894.RAF3ERlCqATNhIs1ibSoE-GqITCKdcja1srqttUge06A8130_provenance.
• NP137268.RAJ8u5hsp99nSNkdI0Wk2HubJA2jZhG1-eSyD_aph0-_c130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP137268.RAJ8u5hsp99nSNkdI0Wk2HubJA2jZhG1-eSyD_aph0-_c130_provenance.
• NP137273.RALi94h6DoK_n93Mpf3f-9sNgc-Q-SpB7MwFzU9JM-hsk130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP137273.RALi94h6DoK_n93Mpf3f-9sNgc-Q-SpB7MwFzU9JM-hsk130_provenance.
• NP137275.RAOVzcWAYZtZlGGsq5YKUBky8w0nebVXqdOYb9YZx-VvA130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP137275.RAOVzcWAYZtZlGGsq5YKUBky8w0nebVXqdOYb9YZx-VvA130_provenance.
• NP137276.RAKA2JTt6i2rHmB5izRfuBneMIdTuNzIFDbF7UhgI_uRg130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP137276.RAKA2JTt6i2rHmB5izRfuBneMIdTuNzIFDbF7UhgI_uRg130_provenance.
• NP137277.RAM94ZY1R-Qq1mzM1Aj2VoRtd8RXPoS-PcrXDUH56pCOk130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP137277.RAM94ZY1R-Qq1mzM1Aj2VoRtd8RXPoS-PcrXDUH56pCOk130_provenance.
• NP710952.RAN5APk_Rsfn-8l6RlC2Du3Cl_xDaAiFPgr8k4dJcvvHw130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710952.RAN5APk_Rsfn-8l6RlC2Du3Cl_xDaAiFPgr8k4dJcvvHw130_provenance.
• NP710956.RAES40225AufGCCKudfK3nGidW6sgyfkH-LKbV3ZRQPSU130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710956.RAES40225AufGCCKudfK3nGidW6sgyfkH-LKbV3ZRQPSU130_provenance.
• NP137272.RA56kdFgFRN1ReHpY9y_PSi2DWQ2GQEXA9dTaL_qs8yco130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP137272.RA56kdFgFRN1ReHpY9y_PSi2DWQ2GQEXA9dTaL_qs8yco130_provenance.
• NP710953.RAy4Y8texHpnxBJxzbNE9D3AKbuxUeVJ0-mgX3kAnEEWE130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710953.RAy4Y8texHpnxBJxzbNE9D3AKbuxUeVJ0-mgX3kAnEEWE130_provenance.
• NP710954.RA9w_fygJmjk5NLxHqYTZaGpXQWv0t5ZckHSDk0ynzRj8130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710954.RA9w_fygJmjk5NLxHqYTZaGpXQWv0t5ZckHSDk0ynzRj8130_provenance.
• NP710957.RA_mBWZ1GappyFYvadCOLo2Ed3D83sTv3Ax_01tLPf6Do130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710957.RA_mBWZ1GappyFYvadCOLo2Ed3D83sTv3Ax_01tLPf6Do130_provenance.